The pricing, the insurance, and the value all factor into the overall cost of long-term therapy and each should be considered against the alternatives and possible health benefits
Whats more, over a dozen potential new GLP-1 RAs are being developed [archived link]
Several additional percentage points of weight loss translate to significantly greater improvements in metabolic health markers, joint pain, mobility, and quality of life measures
These are all concerns I had while researching semaglutide, the active ingredient in Ozempic, Wegovy, and similar medications
These typically occur in 20-40% of patients and include: Nausea (most common, especially during dose increases) Vomiting Diarrhea Stomach pain Decreased appetite Constipation These side effects usually improve over time as your body adjusts to the medication
LISTEN | Why a weight-loss drug went viral: